A trial to evaluate the effects of dutasteride in combination with imidafenacin therapy in patients with benign prostate hyperplasia (BPH) who had large prostate volume (PV) and remaining overactive bladder (OAB) symptoms despite tamsulosin treatment

Trial Profile

A trial to evaluate the effects of dutasteride in combination with imidafenacin therapy in patients with benign prostate hyperplasia (BPH) who had large prostate volume (PV) and remaining overactive bladder (OAB) symptoms despite tamsulosin treatment

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Dutasteride (Primary) ; Imidafenacin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top